asco 2013: delayed relapse of advanced ovarian cancer when treating with pazopanib
Published 11 years ago • 411 plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
3:21
pazopanib delays progression of advanced ovarian cancer
-
0:59
dr. andreas du bois on maintenance pazopanib in advanced ovarian cancer
-
1:12
dr. du bois on extending pfs in ovarian cancer with pazopanib
-
3:35
asco highlights: bevacizumab for relapsed ovarian cancer
-
1:12
dr. carol aghajanian on the angiogenesis inhibitor pazopanib in ovarian cancer
-
2:22
dr. andreas du bois reviews maintenance pazopanib in ovarian cancer
-
2:19
asco highlights: keynote100
-
9:49
asco 2013: science behind phase i clinical trials: targeting tumour cell development pathways
-
0:38
controlling advanced ovarian cancer
-
1:03
asco 2012 - study about patient preference for pazopanib
-
2:36
joanne mortimer, md: pazopanib maintenance therapy
-
2:51
gynaecology highlights from asco 2018
-
3:23
gyn onc at asco 2016: ovarian cancer
-
7:14
asco 2010: ovarian cancer research
-
5:06
asco22 gynecologic oncology: relacorilant combined with nab-paclitaxel in recurrent ovarian cancer
-
3:21
asco: targeted agent slows recurrent ovarian cancer
-
0:59
dr. molina discusses recent pazopanib clinical trials
-
3:39
asco: secondary cytoreductive surgery in recurrent ovarian cancer